Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Santos Ribeiro (Brussels, Belgium), M. Lecocq (Brussels, Belgium), M. De Beukelaer (Brussels, Belgium), C. Bouzin (Brussels, Belgium), Y. Yakoub (Brussels, Belgium), R. Quarck (Leuven, Belgium), O. Vancaenegem (Brussels, Belgium), F. Huaux (Brussels, Belgium), S. Horman (Brussels, Belgium), F. Perros (Paris, France), L. Godinas (Leuven, Belgium), C. Pilette (Brussels, Belgium). Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension. 3277

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study) Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021 Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Late Breaking Abstract - WEAning From NonInvasive Ventilation – ‘WEANIV’ Study Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey. Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Late Breaking Abstract - Hypoxic Challenge Testing: Practice Experience In Tallaght Hospital\Dublin."Time to improve training for hypoxic pulmonary challenge test" Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018 Late Breaking Abstract - Pulmonary function in children and adolescents after COVID-19 Source: Virtual Congress 2021 – Best of paediatric physiology and sleep research Year: 2021 Late Breaking Abstract - Covid-19 management in an Italian Prison. Monitoring of pulmonary function using oscillometry. Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Late Breaking Abstract - Influence of Weather Conditions on the Onset of Primary Spontaneous Pneumothorax: Positive Association with Occurrence of “clusters” Source: International Congress 2017 – Late-breaking studies in pulmonary diseases Year: 2017 Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT Year: 2018 Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Late Breaking Abstract - A Pilot study of a novel Endoscopic Lung Volume Reduction device Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm. Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Late Breaking Abstract - First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB) Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations Year: 2018